← Open Payments lookup

TIMOTHY SOUTH: Open Payments

NPI 1376506741 · KOSCIUSKO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$874 in 41 payments from 10 companies in 2025. Trend: 2023 $1,341 · 2024 $1,465 · 2025 $874

Food & beverage: $874
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$364
Novo Nordisk Inc10$171
PFIZER INC.4$75
ABBVIE INC.4$65
Otsuka America Pharmaceutical, Inc.2$60
GlaxoSmithKline, LLC.3$46
Bayer Healthcare Pharmaceuticals Inc.2$28
Averitas Pharma Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Sumitomo Pharma America, Inc.1$14

Products named: AIRSUPRA, BREZTRI, Ozempic, REXULTI, TRELEGY ELLIPTA, PREVNAR 20, Rybelsus, UBRELVY.

Industry payments across MS — which companies pay providers there.